K Number
K220227
Device Name
Auto Folding Scooter, S21F
Date Cleared
2022-10-12

(258 days)

Product Code
Regulation Number
890.3800
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.
Device Description
The Auto Folding Scooter S21F is designed for indoor use for adults with mobility restrictions. It is classified as Class II medical device per US FDA 21 CFR 890.3800. It is compact, maneuverable and not necessarily able to overcome obstacles. The maximum load is 115 kg. The product is not intended for visually impaired people. The drivers need to be mentally and physically suitable to drive the scooters. The fingers need to work functionally. The driving distance will be reduced if the scooter is used frequently on slopes, rough ground or climbing curb. The scooter is not for use as a seat in motor vehicle. Auto Folding Scooter S21F is battery powered and configured with four solid wheels (03) (08), a seat (04), a handle bar to control the driving function (01), a cross bar (05), a main frame (06), a foot-rest (02), a back-rest (04), a set of 2 anti-tippers (09), referred to the components and parts diagrams of S21F below. S21F is driven by two solid rear wheels (08) as the drive wheel, two solid front castors (03) as the steering wheel, using the steering handles (01) to control the front frame assembly (02) to control the front wheels (03) as the power scooter steering direction mechanism. Steering handles (01) is able to control driving forward, driving backward, speed control. The main frame (06) is equipped with a rear bumper to allow the scooter to sustain an impact without damage to the power scooter safety system. The maximum loading weight of S21F is 253 lbs. (115 kg), and its maximum speed is 3.75 mph (6 km/h). The dimensions of (Length * Width *Height) of the unfolded device are 33.0" x 18.1" x 30.3" (840 mm x 460 mm x 770 mm) and 28.7" x 17.3" x 16.5" (730 mm * 420 mm * 420 mm) for the folded device. The weight of the device is 51.8 lbs. (23.5 kg) with battery and 46.9 lbs. (21.3 kg) without battery. Seat belt is a standard accessory to S21F power scooter, and is not a 510(k)-clearance accessory. It can be installed onto the seat (as seen in the diagram below) by consulting with the local authorized dealer for seat belt installation.
More Information

Not Found

No
The description focuses on mechanical and electrical components and standard safety/performance testing, with no mention of AI, ML, or related concepts.

No
The device is a mobility scooter intended to provide mobility, not to treat or cure a disease or condition. It is a Class II medical device, specifically a "Motorized three-wheeled vehicle," which falls under the category of "Physical medicine therapeutic devices." However, its intended use is for mobility assistance rather than therapeutic intervention.

No

The device is described as an "Auto Folding Scooter S21F" and its intended use is "to provide mobility to persons restricted to a sitting position." There is no mention of it being used to diagnose any condition or disease. It is classified under 21 CFR 890.3800 which is for Manual Labeled Wheelchair, which is not a diagnostic device.

No

The device description clearly outlines a physical, battery-powered scooter with multiple hardware components (wheels, seat, handle bar, frame, etc.) and mentions performance testing related to physical attributes and electrical safety. It is not solely software.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is "to provide mobility to persons restricted to a sitting position." This is a physical function, not a diagnostic one.
  • Device Description: The description details a mobility scooter with components like wheels, a seat, handlebars, etc. These are all related to physical movement and support, not to testing samples from the human body.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting diseases or conditions through in vitro methods, or providing information for diagnosis, monitoring, or treatment decisions based on such analysis.
  • Classification: The device is classified as a Class II medical device per US FDA 21 CFR 890.3800, which is the regulation for Powered Scooters. This classification is for mobility aids, not IVDs.

In summary, the device's purpose, description, and regulatory classification clearly indicate it is a mobility device and not an In Vitro Diagnostic.

N/A

Intended Use / Indications for Use

The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.

Product codes (comma separated list FDA assigned to the subject device)

INI

Device Description

The Auto Folding Scooter S21F is designed for indoor use for adults with mobility restrictions. It is classified as Class II medical device per US FDA 21 CFR 890.3800. It is compact, maneuverable and not necessarily able to overcome obstacles. The maximum load is 115 kg.

The product is not intended for visually impaired people. The drivers need to be mentally and physically suitable to drive the scooters. The fingers need to work functionally. The driving distance will be reduced if the scooter is used frequently on slopes, rough ground or climbing curb. The scooter is not for use as a seat in motor vehicle.

Auto Folding Scooter S21F is battery powered and configured with four solid wheels (03) (08), a seat (04), a handle bar to control the driving function (01), a cross bar (05), a main frame (06), a foot-rest (02), a back-rest (04), a set of 2 anti-tippers (09), referred to the components and parts diagrams of S21F below.

S21F is driven by two solid rear wheels (08) as the drive wheel, two solid front castors (03) as the steering wheel, using the steering handles (01) to control the front frame assembly (02) to control the front wheels (03) as the power scooter steering direction mechanism. Steering handles (01) is able to control driving forward, driving backward, speed control. The main frame (06) is equipped with a rear bumper to allow the scooter to sustain an impact without damage to the power scooter safety system. The maximum loading weight of S21F is 253 lbs. (115 kg), and its maximum speed is 3.75 mph (6 km/h). The dimensions of (Length x Width x Height) of the unfolded device are 33.0" x 18.1" x 30.3" (840 mm x 460 mm x 770 mm) and 28.7" x 17.3" x 16.5" (730 mm x 420 mm x 420 mm) for the folded device. The weight of the device is 51.8 lbs. (23.5 kg) with battery and 46.9 lbs. (21.3 kg) without battery. Seat belt is a standard accessory to S21F power scooter, and is not a 510(k)-clearance accessory. It can be installed onto the seat (as seen in the diagram below) by consulting with the local authorized dealer for seat belt installation.

The static stability results of tilt over tests performed laterally, posteriorly and anteriorly with a user of maximum allowable weight 253 lbs. and a fixed seat height 14.8" (376 mm) are 3 degrees for three cases.

There are no any external wired and /or wireless communication interfaces which may impact the cybersecurity information of our subject device. The following surfaces are recommended NOT to operate on:

  • Sand surface A
  • A Wet or icy surface
  • A Road maintenance hole metal cover
  • A Avoid going up multiple steps.
  • A Avoid using escalators. Use the elevator.
  • A Too steep incline over 3 degrees.
  • A Ground clearance to battery: 1.18" (30 mm)
  • A Curb climbing ability: 0.59" (15 mm)

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

adults

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

EMC & Electrical Safety Testing and Performance Bench Testing are conducted per the following standards:

  • EMC standards (applied for S21F & Charger)
    • ISO 7176-21:2009 Wheelchairs Part 21: Requirements and test method . for electromagnetic compatibility of electrically powered wheelchairs and scooters, and battery chargers
    • RESNA WC-2:2019 Section 21: 2009 Requirements and test methods for electromagnetic compatibility of electrically powered wheelchairs and motorized scooters
  • Electrical Safety standards (applied for battery chargers: METCO, NL07C-25HT)
    • . ANSI/AAMI ES60601-1:2005/(R)2012 and A1:2012, Medical electrical equipment-Part 1: General requirements for basic safety and essential performance
  • Scooter safety performance standards applied for S21F
    • . ISO 7176-1, -3, -5, -7, -8, 15, -22 series & RESNA WC-1 series
    • . ISO 7176-2, -4, -6, -9, -10 series & RESNA WC-2 series
    • ISO 7176-11, ISO 7176-13
    • I ISO 7176-14:2008 Wheelchairs -- Part 14: Power and control systems for electrically powered wheelchairs and scooters -- Requirements and test methods
    • . RESNA WC-2 Section 14:2009 - Power and control systems for electrically powered wheelchair and scooters - Requirements and test methods
    • . ISO 7176-16:2012 Resistance to Ignition of Postural Support Devices Test

Key Results:
The subject device meets the performance requirements of ISO 7176 series, ISO 7176-14-2008: Power and control systems for electrically powered wheelchairs and scooters - Requirements and test method. and RESNA WC-2 Sec 14: Power and control systems for electrically powered wheelchairs and scooters- Requirements and test methods.
The Lithium-ion battery for the subject device has passed the requirements of ISO 7176-14:2008 and RESNA WC-2 Sec 14.
The battery charger for the subject device passes the EMC standard: ISO 7176-21:2009, and Electrical Safety standard: ANSI/AAMI ES60601-1:2005/(R)2012 and A1:2012.
The patient-contacting parts of the subject device passed biocompatibility testing per ISO 10993-5:2009 and ISO 10993-10:2010.
The Dynamic R-series DR50 controller used with the subject device S21F passed the ISO 7176-14:2008 and RESNA WC-2 Sec 14:2009.
The motor used in the subject device passed the requirements of the EMC standards: ISO 7176-21:2009. RESNA WC-2 Sec 21:2009. and performance standards: ISO 7176-14:2008, and RESNA WC-2 Sec 14:.2009.
The subject device passes the EMC testing per ANSI/RESNA WC-2:2009 Section 21 & ISO 7176-21:2009, and the performance testing per ISO 7176-14:2008 and RESNA WC-2 Section 14.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

Heartway Medical Products Co., Ltd. Power Mobility Scooter, Brio S19 K150987

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 890.3800 Motorized three-wheeled vehicle.

(a)
Identification. A motorized three-wheeled vehicle is a gasoline-fueled or battery-powered device intended for medical purposes that is used for outside transportation by disabled persons.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

October 12, 2022

Heartway Medical Products Co., Ltd. % Ke-Min Jen Contact Person Roc Chinese-European Industrial Research Society No. 58. Fu Chiun Street Hsin Chu City, Taiwan 30067 Taiwan

Re: K220227

Trade/Device Name: Auto Folding Scooter, S21F Regulation Number: 21 CFR 890.3800 Regulation Name: Motorized Three-Wheeled Vehicle Regulatory Class: Class II Product Code: INI Dated: September 6, 2022 Received: September 14, 2022

Dear Ke-Min Jen:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

1

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

for Tushar Bansal, PhD Acting Assistant Director, Acute Injury Devices Team DHT5B: Division of Neuromodulation and Physical Medicine Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K220227

Device Name Auto Folding Scooter, S21F

Indications for Use (Describe)

The device is intended for medical purposes to provide mobility to persons restricted to a sitting position

Type of Use (Select one or both, as applicable)

| Prescription Use (Part 21 CFR 801 Subpart D)

X Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Image /page/3/Picture/0 description: The image shows the logo for Heartway. The logo features a blue square at the top, with a stylized pink butterfly-like design inside. Below the square, the word "HEARTWAY" is written in a bold, sans-serif font.

HEARTWAY MEDICAL PRODUCTS CO., LTD. No. 18, Jingke Central 1st Rd., Nantun Dist., Taichung City 408, Taiwan TEL: +886-4-23583232 FAX: +886-4-23590786 E-mail: sales(@heartway.com.tw

510(k) number: K220227 510(k) Summary

| Submitter's Name: | HEARTWAY Medical Products Co., Ltd.
No.18, Jingke Central 1st Rd., Nantun Dist., Taichung City,
Taiwan, R.O.C. 40852 |

------------------------------------------------------------------------------------------------------------------------------------------------------
Date summary prepared:October 12, 2022
Proprietary Name:HEARTWAY Auto Folding Scooter, S21F
Common or Usual Name:POWERED SCOOTER
Classification Name:Vehicle, Motorized 3- Wheeled (Class II, 21 CFR 890.3800)
Product Code:INI
Official Correspondent:Dr. KE-MIN JEN (email: ceirs.jen@msa.hinet.net)
TEL:886-3-5208829
Predicate Device:Heartway Medical Products Co., Ltd.
Power Mobility Scooter, Brio S19
K150987

● Indications for Use:

The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.

. Description of the device:

The Auto Folding Scooter S21F is designed for indoor use for adults with mobility restrictions. It is classified as Class II medical device per US FDA 21 CFR 890.3800. It is compact, maneuverable and not necessarily able to overcome obstacles. The maximum load is 115 kg.

The product is not intended for visually impaired people. The drivers need to be mentally and physically suitable to drive the scooters. The fingers need to work functionally. The driving distance will be reduced if the scooter is used frequently on slopes, rough ground or climbing curb. The scooter is not for use as a seat in motor vehicle.

4

Image /page/4/Picture/0 description: The image shows the logo for HEARTWAY. The logo features a blue square in the background with a pink butterfly-like shape in the foreground. Below the graphic is the word "HEARTWAY" in a bold, sans-serif font.

HEARTWAY MEDICAL PRODUCTS CO., LTD. No. 18, Jingke Central 1st Rd., Nantun Dist., Taichung City 408, Taiwan TEL: +886-4-23583232 FAX: +886-4-23590786 E-mail: sales(@heartway.com.tw http://www.heartway.com.tw

Auto Folding Scooter S21F is battery powered and configured with four solid wheels (03) (08), a seat (04), a handle bar to control the driving function (01), a cross bar (05), a main frame (06), a foot-rest (02), a back-rest (04), a set of 2 anti-tippers (09), referred to the components and parts diagrams of S21F below.

S21F is driven by two solid rear wheels (08) as the drive wheel, two solid front castors (03) as the steering wheel, using the steering handles (01) to control the front frame assembly (02) to control the front wheels (03) as the power scooter steering direction mechanism. Steering handles (01) is able to control driving forward, driving backward, speed control. The main frame (06) is equipped with a rear bumper to allow the scooter to sustain an impact without damage to the power scooter safety system. The maximum loading weight of S21F is 253 lbs. (115 kg), and its maximum speed is 3.75 mph (6 km/h). The dimensions of (Length * Width *Height) of the unfolded device are 33.0" x 18.1" x 30.3" (840 mm x 460 mm x 770 mm) and 28.7" x 17.3" x 16.5" (730 mm * 420 mm * 420 mm) for the folded device. The weight of the device is 51.8 lbs. (23.5 kg) with battery and 46.9 lbs. (21.3 kg) without battery. Seat belt is a standard accessory to S21F power scooter, and is not a 510(k)-clearance accessory. It can be installed onto the seat (as seen in the diagram below) by consulting with the local authorized dealer for seat belt installation.

Image /page/4/Picture/4 description: The image shows a line drawing of what appears to be a car frame. The frame is mostly rectangular with curved edges. There are also some wires and tubes attached to the frame, possibly indicating the car's electrical or plumbing system. The drawing is simple and lacks detail, focusing on the basic structure of the car frame.

Seat belt of S21F

The static stability results of tilt over tests performed laterally, posteriorly and anteriorly with a user of maximum allowable weight 253 lbs. and a fixed seat height 14.8" (376 mm) are 3 degrees for three cases.

There are no any external wired and /or wireless communication interfaces which may impact the cybersecurity information of our subject device. The following surfaces are recommended NOT to operate on:

  • Sand surface A
  • A Wet or icy surface
  • A Road maintenance hole metal cover
  • A Avoid going up multiple steps.

5

Image /page/5/Picture/0 description: The image shows the logo for Heartway. The logo features a blue square with a pink butterfly-like design inside. Below the square, the word "HEARTWAY" is written in a bold, sans-serif font.

HEARTWAY MEDICAL PRODUCTS CO., LTD. No. 18, Jingke Central 1st Rd., Nantun Dist., Taichung City 408, Taiwan TEL: +886-4-23583232 FAX: +886-4-23590786 E-mail: sales(@heartway.com.tw http://www.heartway.com.tw

  • A Avoid using escalators. Use the elevator.
  • A Too steep incline over 3 degrees.
  • A Ground clearance to battery: 1.18" (30 mm)
  • A Curb climbing ability: 0.59" (15 mm)

EMC & Electrical Safety Testing and Performance Bench Testing are conducted per the following standards:

  • EMC standards (applied for S21F & Charger)
    • ISO 7176-21:2009 Wheelchairs Part 21: Requirements and test method . for electromagnetic compatibility of electrically powered wheelchairs and scooters, and battery chargers
    • RESNA WC-2:2019 Section 21: 2009 Requirements and test methods for electromagnetic compatibility of electrically powered wheelchairs and motorized scooters
  • Electrical Safety standards (applied for battery chargers: METCO, NL07C-25HT)
    • . ANSI/AAMI ES60601-1:2005/(R)2012 and A1:2012, Medical electrical equipment-Part 1: General requirements for basic safety and essential performance
  • Scooter safety performance standards applied for S21F
    • . ISO 7176-1, -3, -5, -7, -8, 15, -22 series & RESNA WC-1 series
    • . ISO 7176-2, -4, -6, -9, -10 series & RESNA WC-2 series
    • ISO 7176-11, ISO 7176-13
    • I ISO 7176-14:2008 Wheelchairs -- Part 14: Power and control systems for electrically powered wheelchairs and scooters -- Requirements and test methods
    • . RESNA WC-2 Section 14:2009 - Power and control systems for electrically powered wheelchair and scooters - Requirements and test methods
    • . ISO 7176-16:2012 Resistance to Ignition of Postural Support Devices Test

6

Image /page/6/Picture/0 description: The image shows the logo for Heartway. The logo features a stylized pink butterfly shape against a blue background. Below the graphic is the word "HEARTWAY" in a bold, black sans-serif font.

HEARTWAY MEDICAL PRODUCTS CO., LTD.

No. 18, Jingke Central 1st Rd., Nantun Dist., Taichung City 408, Taiwan TEL: +886-4-23583232 FAX: +886-4-23590786 E-mail: sales@heartway.com.tw

● Biocompatibility information

Patient-contacting partsMaterialsTesting standardsTesting laboratoryVerdictAttached files
Dial set &
Handle barDIOSHY® TPU
(Thermoplastic
Urethane)*ISO 10993-5:2009
in vitro Cytotoxicity test*Super Laboratory Co., Ltd.PassVOL_015_003
*ISO 10993-10:2010 Maximization
Sensitization test*Super Laboratory Co., Ltd.PassVOL_015_004
*ISO 10993-10:2010 Skin Irritation
test*Super Laboratory Co., Ltd.PassVOL_015_005
Seat cushionPU Foam*ISO 10993-5:2009
in vitro Cytotoxicity test*SGS Taiwan Ltd.
Ultra Trace &
Industrial Safety
HygienePassVOL_015_006
*ISO 10993-10:2010
Maximization Sensitization test*SGS Mechanical
& Hardgoods LabPassVOL_015_007
*ISO 10993-10:2010
Skin Irritation test*SGS Mechanical
& Hardgoods LabPassVOL_015_008
Seat leather
Seat beltVinyl Fabric*ISO 10993-5:2009
in vitro Cytotoxicity test*SGS Mechanical
& Hardgoods LabPassVOL_015_009
*ISO 10993-10:2010
Maximization Sensitization test*SGS Mechanical
& Hardgoods LabPassVOL_015_010
*ISO 10993-10:2010
Skin Irritation test*SGS Mechanical
& Hardgoods LabPassVOL_015_011

7

Image /page/7/Picture/0 description: The image shows the logo for HEARTWAY. The logo features a blue square with a pink butterfly-like design inside. Below the square, the word "HEARTWAY" is written in a bold, sans-serif font.

HEARTWAY MEDICAL PRODUCTS CO., LTD.

No. 18, Jingke Central 1st Rd., Nantun Dist., Taichung City 408, Taiwan TEL: +886-4-23583232 FAX: +886-4-23590786 E-mail: sales@heartway.com.tw

Comparison ItemPredicate deviceSubject (New) DeviceVerdict
ManufacturerHeartway medical products Co.,
Ltd.Heartway Medical Products Co.,
Ltd.--
Trade NamePower mobility scooterAuto Folding Scooter--
Model NameBrio S19S21F--
510(K) NumberK150987To Be Assigned--
Indications for UseThe device is intended for
medical purposes to provide
mobility to persons restricted to
a sitting position.The device is intended for
medical purposes to provide
mobility to persons restricted to
a sitting position.Same
Number of Wheels44Same
Anti-TipperOne set of 2 anti-tippersOne set of 2 anti-tippersSame
Frame TypeFixed / Aluminum alloyFixed / Aluminum alloySame
Biocompatibility testingIso 10993-1:2009
Iso 10993-5:2009
Iso 10993-10:2010ISO 10993-1:2009
ISO 10993-5:2009
ISO 10993-10:2010Same
Rear WheelsSize 8" x 2"
Type Pu Solid Tire x 2Size 8" x 2"
PU solid tire x 2Same
Front CastorSize 7" x 1.6"
Type Pu Solid Tire x 2Size 7" x 1.6"
PU solid tire x 2Same
Armrest typeNANASame
Wheel Lock typePush-to- lockPush-to- LockSame
Upholstery
inflammability testingPassPassSame
Overall DimensionsLength 36.6" (930 mm)
Width 19.0" (485 mm)
Height 37.2" (945 mm)33.0" (840 mm)
18.1" (460 mm)
30.3" (770 mm)Different
Folded Dimensions
(L x W x H)36.6" x 19" x 13.3"
(930 x 485 x 340) mm28.7" x 17.3" x 16.5"
(730 x 440 x 420) mmDifferent
Weight Capacity220 lbs. (100 kg)253 lbs. (115 kg)Different
Max Speed5.0 mph (8.0 km/h)3.75 mph (6 km/h )Different
Battery RatingTwo 12 Vdc, 12 Ah
Sealed lead acid BatteriesOne 25.2 Vdc, 11.5 Ah
Lithium-ion BatteryDifferent
Off-board external type
CTE 4C24050A
Input: 110 -240 Vac, 50 Hz, 2 A
Output: 24 Vdc, 5 AOff -board external type
METCO, NL07C-25HT
Input: 110-240 Vac, 50/60 Hz, 84 W
Output: 29.05 Vdc, 2.5 ADifferent
Charger Type
Cruise Range11.25 miles (18 km)9.3 miles (15 km )Different
Patient- contacting parts and materialsSeat -PVC material
Hand grip - PVC material
Safety belt - PVC materialDial set / Handle bar: TPU
Seat cushion: PU Foam
Seat & backrest leather: Vinyl FabricDifferent
Controller TypePenny & Giles S-driveDynamic, R series, DR50Different
Motor Type3A, 24 Vdc / 270 W2.5 A max, 24 Vdc, 180 WDifferent
Scooter Weight:with Battery 69 lbs. (31.3 Kg)
without Battery 53 lbs. (24.0 Kg )51.8 lbs. (23.5 kg)
46.9 lbs. (21.3 kg)Different
SuspensionCross braceNoneDifferent
Turning Radius32.2" (820 mm)43.7" / 1110 mmDifferent
Static / Dynamic
Stabilities (Degrees)10 /66 / 3Different
Ground Clearance2.3" (60 mm)1.18" (30 mm)Different
Kerb Climbing Ability1.7" (45 mm)0.59" (15 mm)Different
Warranty3 years: main frame
1 year: controller /gear motor /batteries
Without exhaustive and wear parts2 years: Main frame
1.5 years: Controller
1 year: Charger
Without exhaustive and wear partsSimilar

● Comparison table

8

Image /page/8/Picture/0 description: The image shows the logo for Heartway. The logo features a blue square with a pink butterfly-like design inside. Below the square, the word "HEARTWAY" is written in bold, black letters.

HEARTWAY MEDICAL PRODUCTS CO., LTD.

No. 18, Jingke Central 1st Rd., Nantun Dist., Taichung City 408, Taiwan TEL: +886-4-23583232 FAX: +886-4-23590786 E-mail: sales@heartway.com.tw

9

Image /page/9/Picture/0 description: The image shows a logo for HEARTWAY. The logo features a blue square with a pink butterfly-like design inside. Below the square, the word "HEARTWAY" is written in a bold, black font.

HEARTWAY MEDICAL PRODUCTS CO., LTD. No. 18, Jingke Central 1st Rd., Nantun Dist., Taichung City 408, Taiwan TEL: +886-4-23583232 FAX: +886-4-23590786 E-mail: sales@heartway.com.tw http://www.heartway.com.tw

● COMPARISON DISCUSSION

Both devices are classified as Vehicle, Motorized 3-Wheeled per 21 CFR 890.3800 under product code INI. The indications for use for both devices are the same. Both devices, Brio S19 and S21F, use the same scooter technologies.

The overall dimensions of the subject device are smaller than those of the predicate device. Both devices, Brio S19 and S21F, are designed to function as small-scale motorized 3-wheeled vehicles, so their overall dimensions and weight capacities are small and similar, and their differences are not large. The subject device S21F meets the performance requirements of ISO 7176 series, ISO 7176-14-2008: Power and control systems for electrically powered wheelchairs and scooters - Requirements and test method. and RESNA WC-2 Sec 14: Power and control systems for electrically powered wheelchairs and scooters- Requirements and test methods. There are no any new safety and effectiveness concerns raised by the S21F due to the minor differences of the overall dimensions and weight capacity.

The folded dimensions of both devices are different, and the length and width of S21F while folded are smaller than Brio S 19 and height of the S21F while folded is larger than the Brio S19. We fold the scooter when transported, and smaller length and width need less space of the motor vehicle to store the scooter, and this brings out more convenience for the patient. There are no any new safety and effectiveness concerns raised by S21F due to the smaller volume or space of S21F.

The maximum speed for the subject device is 3.75 mph and the predicate device has maximum speed of 5.0 mph. Regarding the subject device has a slower maximum speed, it has higher dynamic stability performance than the predicate device. So. there are no any new safety and effectiveness concerns raised by the subject device S21F.

The battery ratings for both devices are different. The predicate device used two sealed lead acid batteries rating at 12 Vdc, 12 Ah, and the subject device used one Lithium -ion battery rating at 25.2 Vdc, 11.5 Ah. The Lithium-ion battery for the subject device has passed the requirements of ISO 7176-14:2008 and RESNA WC-2 Sec 14, so there are no any new safety and effectiveness concerns raised by S21F.

10

Image /page/10/Picture/0 description: The image shows the logo for HEARTWAY. The logo features a stylized pink butterfly shape above the word "HEARTWAY" in black, block letters. The butterfly is composed of four heart shapes, and the background behind the butterfly is a blue square.

HEARTWAY MEDICAL PRODUCTS CO., LTD. No. 18, Jingke Central 1st Rd., Nantun Dist., Taichung City 408, Taiwan TEL: +886-4-23583232 FAX: +886-4-23590786 E-mail: sales@heartway.com.tw

Because the subject device uses a new type battery: Lithium-ion battery charger is also adapted to use the METCO Lithium-ion battery charger NL07-25HT. The battery chargers for the predicate and subject devices are different, but the battery charger for the subject device passes the EMC standard: ISO 7176-21:2009, and Electrical Safety standard: ANSI/AAMI ES60601-1:2005/(R)2012 and A1:2012. There are no any new safety and effectiveness concerns raised by using different battery charger for the subject device S21F.

The cruise ranges for the predicate and the subject devices are 11.25 miles and 9.3 miles. The cruise range of S21F is less than the predicate device, and this difference relates with the frequency of battery charging and how far the patient will get to. The difference of the cruise ranges will not raise any new safety and effectiveness concerns for the subject device.

The patient-contacting parts and materials are different for both devices. But, the patient-contacting parts of the subject device passed biocompatibility testing per ISO 10993-5:2009 and ISO 10993-10:2010, the differences between them are not to raise any new safety and effectiveness concerns for the subject device.

The electronic controllers used by two devices are different. The Dynamic R-series DR50 controller used with the subject device S21F passed the ISO 7176-14:2008 and RESNA WC-2 Sec 14:2009. There are no any new safety and effectiveness concerns raised by the S21F due to using different electronic controllers.

The motor types for both devices are different. The predicate device uses motor of 270 W / 24 Vdc / 3A, and the subject device uses motor of 180 W /24 Vdc / 2.5 A. But the motor used in the subject device passed the requirements of the EMC standards: ISO 7176-21:2009. RESNA WC-2 Sec 21:2009. and performance standards: ISO 7176-14:2008, and RESNA WC-2 Sec 14:.2009. So, there are no any new safety and effectiveness concerns raised due to different motor used by the subject devices.

With the advancement of battery technology, S21F now uses one Lithium-ion battery, instead of using two Sealed Lead Acid batteries. The weight of one Lithium-ion battery is only 4.9 lbs. and the total weight of two Sealed Lead Acid batteries is 16 lbs. So, the scooter weight with battery for the S21F is 51.8 lbs. and the predicate device with battery weighs 69 lbs. There are no any new safety and effectiveness concerns raised by the different scooter weights.

11

Image /page/11/Picture/0 description: The image shows a logo for "HEARTWAY". The logo features a stylized pink butterfly-like shape against a blue square background. Below the graphic is the word "HEARTWAY" in a bold, sans-serif font.

HEARTWAY MEDICAL PRODUCTS CO., LTD. No. 18, Jingke Central 1st Rd., Nantun Dist., Taichung City 408, Taiwan TEL: +886-4-23583232 FAX: +886-4-23590786 E-mail: sales(@heartway.com.tw

There is a suspension system for the predicate device and no suspension for the subject device. The suspension used by the predicate device is installed to decrease the impact from ground to the patient, since the maximum speed of the subject device is 3.75 mph, which is less than the predicate device of 5 mph; there is no need to install suspension system on the S21F to reduce the impact to the scooter. Without suspension system for the subject device will let the patient feel more impact from the ground, but this is not related with the safety and effectiveness.

The turning radius for the predicate device is 32.2" and it is 43.7" for the subject device. A smaller turning radius will let the scooter move in a smaller space. But this is not related to the safety and effectiveness.

The static/dynamic stabilities for the subject device are 6/3 degrees, which are lower than the predicate device 10/6 degrees. We place the safety notice in the user manual to inform the users of these limitations - not to use the device on the slope angle greater than 3 degrees or not to use it outdoors. We install a set of anti-tippers on the back of the S21F to prevent the tipping on the slope. By doing these actions, there are no any new safety and effectiveness concerns raised by S21F due to the smaller stabilities of the subject device.

The ground clearance for the predicate device is 2.3" and it is 1.18" for the subject device. So, there are more limitations for the subject device than the predicate device when moving across an obstruct. But the purpose of the limitations is to let the patient know the capability of the subject device. A smaller clearance will not lead to the dangerous situations, instead it will prevent the patient from the potential harms.

The kerb climbing ability for the predicate device is 1.7" and it is 0.59" for the subject device. A smaller kerb climbing ability will not lead to dangerous situations, but it will bring about more cautions and more safety.

The warranty for the subject device is similar to the predicate device. The different warranty contents will result to the different costs paid by the customers, which is not related to the safety and effectiveness concerns. There are no any new safety and effectiveness concerns raised by the subject device due to the different warranty contents.

12

Image /page/12/Picture/0 description: The image shows the logo for Heartway. The logo features a blue square with a pink butterfly-like design inside. Below the square, the word "HEARTWAY" is written in a bold, sans-serif font.

HEARTWAY MEDICAL PRODUCTS CO., LTD. No. 18, Jingke Central 1st Rd., Nantun Dist., Taichung City 408, Taiwan TEL: +886-4-23583232 FAX: +886-4-23590786 E-mail: sales@heartway.com.tw

At last, the subject device passes the EMC testing per ANSI/RESNA WC-2:2009 Section 21 & ISO 7176-21:2009, and the performance testing per ISO 7176-14:2008 and RESNA WC-2 Section 14. The overall performances of the subject device are ensured.

● CLINICAL INFORMATION

Not Applicable

● CONCLUSIONS

The subject device, HEARTWAY Auto Folding Scooter, S21F, is as safe and effective as, and functions in a manner equivalent to the predicate device, HEARTWAY Power Mobility Scooter, Brio S19 (K150987). The conclusions drawn from the non-clinical tests demonstrate that the device is as safe, as effective, and performs as well as the legally marketed device identified in the submission. Thus, the subject device is substantially equivalent to the predicate device.